2023
DOI: 10.1016/j.jtumed.2022.07.007
|View full text |Cite
|
Sign up to set email alerts
|

The management of retroperitoneal sarcoma: The experience of a single institution and a review of the literature

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 23 publications
0
1
0
Order By: Relevance
“…Liposarcoma is a rare malignancy derived from mesenchymal cells; retroperitoneal liposarcoma (RPLS), which occurs in the retroperitoneal region and is the most common retroperitoneal tumor, accounts for approximately 1% of all malignancies, 25% of all soft tissue sarcomas, and 45% of primary retroperitoneal soft tissue sarcomas (1)(2)(3). RPLS refers to a kind of soft tissue malignant tumor originating from adipose tissue and occurring in the retroperitoneal space.…”
Section: Introductionmentioning
confidence: 99%
“…Liposarcoma is a rare malignancy derived from mesenchymal cells; retroperitoneal liposarcoma (RPLS), which occurs in the retroperitoneal region and is the most common retroperitoneal tumor, accounts for approximately 1% of all malignancies, 25% of all soft tissue sarcomas, and 45% of primary retroperitoneal soft tissue sarcomas (1)(2)(3). RPLS refers to a kind of soft tissue malignant tumor originating from adipose tissue and occurring in the retroperitoneal space.…”
Section: Introductionmentioning
confidence: 99%